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Abstract 
Introduction Approximately 1% of the world’s population is impacted by epilepsy, a 
chronic neurological disorder characterized by seizures. One-third of epileptic pa-
tients are resistant to AEDs, or have medically refractory epilepsy (MRE). One non-
invasive treatment that exists for MRE includes the ketogenic diet (KD), a high-fat, 
low-carbohydrate diet. Despite the KD’s success in seizure attenuation, it has a few 
risks and its mechanisms remain poorly understood. The KD has been shown to im-
prove metabolism and mitochondrial function in epileptic phenotypes. Potassium 
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channels have implications in epileptic conditions as they have dual roles as met-
abolic sensors and control neuronal excitation. 
Objectives The goal of this study was to explore changes in the lipidome in hippocam-
pal and cortical tissue from Kv1.1-KO model of epilepsy. 
Methods FT-ICR/MS analysis was utilized to examine nonpolar metabolome of corti-
cal and hippocampal tissue isolated from a Kv1.1 channel knockout mouse model 
of epilepsy (n = 5) and wild-type mice (n = 5). 
Results Distinct metabolic profiles were observed, significant (p < 0.05) features in 
hippocampus often being upregulated (FC ≥ 2) and the cortex being downregulated 
(FC ≤ 0.5). Pathway enrichment analysis shows lipid biosynthesis was affected. 
Partition ratio analysis revealed that the ratio of most metabolites tended to be in-
creased in Kv1.1−/−. Metabolites in hippocampal tissue were commonly upregu-
lated, suggesting seizure initiation in the hippocampus. Aberrant mitochondrial 
function is implicated by the upregulation of cardiolipin, a common component in 
the mitochondrial membrane. 
Conclusion Generally, our study finds that the lipidome is changed in the hippocam-
pus and cortex in response to Kv1.1-KO indicating changes in membrane structural 
integrity and synaptic transmission. 
Keywords: Seizure, Drug resistant epilepsy, Metabolomics, Lipids, Metabolic profiling 
1  Introduction 
Epilepsy is a progressive, chronic neurological disorder characterized 
by hypersynchronous electrical activity resulting in seizures. Approx-
imately 70 million people worldwide have been diagnosed with epi-
lepsy with 30% of all patients having medically refractory epilepsy 
(MRE), or are resistant to traditional AEDs (Kalilani et al. 2018). The 
few treatments available for MRE include surgical removal of epilep-
tic tissue which carries risk of interfering with normal brain function 
(Kelly and Chung 2011). Another is a vagal nerve stimulator (similar to 
a pacemaker), but carries the risk of interfering with speech or infec-
tion. A non-invasive treatment is the ketogenic diet (KD) (Huttenlocher 
1976). The KD is a high-fat, low-carbohydrate diet that has shown suc-
cess in long term seizure attenuation, particularly in adolescents (Hut-
tenlocher 1976). However, the treatment is associated with risks such 
as palatability with patients, renal damage, and ketoacidosis. Unfortu-
nately, the molecular mechanisms of KD and its impact on MRE remain 
poorly understood. Although recent findings suggest that ion channels 
and neurotransmitter functions may be related to metabolic dysfunction 
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in MRE, it is also suggested that the KD acts by providing an alternative 
metabolic energy source through increased production of ketone bod-
ies (i.e. β-hydroxybutyrate and acetoacetate) (Lutas and Yellen 2013). 
With the effectiveness of the KD affecting changes in metabolism, MRE 
may be a result of metabolic dysfunction rather than neurotransmitter 
function. This is also supported by the fact that alterations in redox bal-
ance and mitochondrial dysfunction have been considered as hallmarks 
of epilepsy (Pearson-Smith and Patel 2017). 
Potassium channels have emerged as a drug target with AEDs (Stas 
et al. 2016). These drugs often control neuronal excitability by increas-
ing the open probability of potassium channels to maintain membrane 
resting potential. Potassium channels act to limit the length of action po-
tentials and maintain the membrane potential. Voltage-gated potassium 
(Kv) channels could serve as a potential target due to their dual role as 
metabolic sensors and regulation of neuronal excitation (Nichols 2006). 
The Kv1.1 channel, encoded by the KCNA1 gene, is located at the axon in 
the hippocampus where it is involved in propagation of action potentials 
and neurotransmitter release (Simeone et al. 2014a, b). When Kv1.1 is 
ablated in mice, it can cause epileptic symptoms resembling temporal 
lobe epilepsy (Robbins and Tempel 2012; Wenzel et al. 2007). The Kv1.1 
knockout (KO) model resembles several other types of epileptic condi-
tions, making it a clinically relevant model to study metabolic abnor-
malities in epilepsy (Simeone et al. 2014a, b). This model has also been 
used to study effects of the KD on metabolism in epilepsy and any addi-
tional impacts on seizure frequency (Kim et al. 2015). Further, supple-
mentation with metabolic intermediates improved mitochondrial func-
tion in mitochondria isolated from Kv1.1- KO mice (Simeone et al. 2014a, 
b). These studies indicate that changes in metabolism play an important 
role in seizures. While majority of studies have focused on the targeted 
polar metabolome (for review, refer to McDonald et al. 2018), the effects 
of the nonpolar lipid metabolome in epilepsy is relatively understudied. 
Lipids represent approximately 10% of the brain’s total mass (Naudí 
et al. 2015). Considering this nontrivial portion of mass, they have many 
functions including regulation in membrane structure, neurotransmit-
ter release, energy metabolism, and as messengers in signaling cascades. 
With lipids playing a potentially important role in almost every aspect 
of neuronal function, it is pertinent to develop a deeper understanding 
of the function of lipids as it relates to neurological diseases. Evidence of 
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dysregulated lipid metabolism has been observed in age-related neuro-
logical diseases (Dodge et al. 2013; Wenk 2005). Changes in membrane 
structure have been shown in several epileptic models as well (Turker 
et al. 2014; Kunduri et al. 2018). It has been observed that there are re-
gional differences in lipid composition in the brain, even within the same 
structure (i.e. ventral hippocampus vs. dorsal hippocampus) (Miranda 
et al. 2019). Further, regional differences in lipid peroxidation have been 
observed in rat brain in response to aging (Baek et al. 1999). With re-
gional differences in lipid composition and metabolism, some may be 
more impacted by seizure activity than others. An aspect of epilepsy that 
remains unexplored is the impact of structural and functional connec-
tions in the brain on seizure initiation and severity. The interconnectiv-
ity of hippocampal and cortical regions are critical to seizure initiation 
and propagation (Vismer et al. 2015). While the hippocampal gyrus is 
often regarded as a “seizure gate”, there are certain regions within the 
brain that support the hypersynchronous activity of seizures and data 
has shown that when these regions (or connections) are disrupted, sei-
zure activity is decreased (Vismer et al. 2015; de Guzman et al. 2004). 
Therefore, by studying the role of lipids in epileptic conditions, poten-
tial future therapeutic targets and/or mechanisms of seizure generation 
can be identified. In this study, FT-ICR/MS analysis have been employed 
to observe changes that occur in the lipidome of hippocampal and cor-
tical tissue isolated from a Kv1.1 KO model of epilepsy. Both regions ex-
hibited distinct lipidomic profiles. Further statistical and pathway anal-
ysis have identified glycerophospholipids as a major lipid class. This 
indicates rearrangement of the membrane composition altering its flu-
idity and permeability—alterations reported in various neurodegener-
ative disorders(Turker et al. 2014; Sooderberg et al. 1992). 
2  Materials and methods 
2.1  Animal studies/mouse tissue collection 
All protocols were performed in accordance with the United States 
Public Health Service’s Policy on Humane Care and Use of Laboratory 
Animals and approved by Creighton University’s Institutional Animal 
Care and Use Committee. Hippocampus and cortex tissue sections were 
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harvested from C3HeB/FeJ wild-type (n = 5) and Kv1.1 KO female mice 
(n = 5) aged between 44 and 50 days as described previously (Roundtree 
et al. 2016). For KO mice, seizure frequency and severity have been pre-
viously established for this model with approximately 7 seizures per 
day, sharp pathological wave (SPW) duration of approximately 80 ms 
and high frequency oscillations in the range of 200–600 Hz (Simeone et 
al. 2014a, b; Roundtree et al. 2016; Fenoglio-Simeone et al. 2009). Mice 
were euthanized using a MMW-05 Muromachi Microwave Fixation sys-
tem (Muromachi Kikai Co.) to minimize metabolic changes through heat 
inactivation of enzymatic activity (Jernerén et al. 2015). Tissue samples 
were stored at − 80 °C until metabolite extraction. 
2.2  Extraction of non‑polar metabolites 
Non-polar metabolite extraction was done using a modified Folch 
method (Folch et al. 1957). Briefly, ZrO bashing beads and 150 mM NaCl 
in 75% MeOH were added to hippocampal or cortical tissue in an Eppen-
dorf tube at a 1:2:0.5 ratio of the following: tissue (mg)/150 mM NaCl 
in 75% MeOH (μL)/ZrO beads (μg). The brain tissue was homogenized 
for 2 min at high speed (power setting of 10) in a Bullet Blender (Next 
Advance, NY) and homogenate (20 μL) moved to the new tube with 180 
μL of 150 mM NaCl and 1 mL of chloroform/MeOH (2:1, v/v) containing 
0.01% butylated hydroxytoluene. Sample was then vortexed for 2 min 
and allowed to stand for 30 min at room temperature. To further sep-
arate phases, the sample was centrifuged at 7800×g for 5 min and the 
lower phase transferred into the new tube. Extracted lipids were dried 
under N2 stream and dissolved in 20 μL of methanol for LC–MS analysis. 
2.3  LC‑FT‑ICR‑MS analysis of lipids 
Metabolites were analyzed using an Agilent 1100 series HPLC connected 
to a Bruker 7.05 T FT-ICR mass spectrometer. Separation of metabolites 
was performed on an ACE5 C8 (100 × 2.1 mm) column at 100 μL/min 
flow rate over 60-min chromatographic run. Mobile phase A consisted 
of 0.1% formic acid (FA) and 10 mM ammonium acetate in water while 
mobile phase B consisted of 0.1% FA and 10 mM ammonium acetate in 
isopropanol/ acetonitrile (50/50; v/v). With a sample injection of 5 μL, 
the following chromatographic conditions were used: initial conditions 
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30% B for 1 min, then increased to 100% B over 24 min and held for 20 
min. To re-equilibrate column, the system returned to the initial condi-
tions (30% B) in 2 min and continue with washing for 13 min. MS was 
operated in positive mode with acquisition range 118–1800 m/z and 0.2 
s ion accumulation time. Estimated resolving power was 78,000 at m/z 
400. Following MS conditions were used: a capillary voltage of 4500 V 
and an end plate offset of -500 V; the dry temperature was set at 180 °C; 
the dry gas flow was maintained 4 L/min. 
2.4  Data processing 
LC–MS data was converted into mzXML format using CompassXport v. 
3.0.6. (Bruker Daltonics) software. Peak detection, alignment, normal-
ization, and retention time collection analyses were done using mzMine 
(Pluskal et al. 2010) and the following parameters: Minimum Standard 
Intensity: 500,000; Retention time (RT) tolerance: 0.2 min; Peak dura-
tion range: 0.2–2 min; Derivatization threshold: 99%; FTMS Shoulder 
peak filter: 10,000; m/z tolerance: 10 ppm. Retention times, peak ar-
eas, and m/z values were exported to Excel tables for further process-
ing. Upon further evaluation of the individual peak chromatograms of 
the samples and blanks, only the peaks with an RT between 9 and 37 min 
were used for further analysis. As expected for lipids and gradient used 
in the method, no significant peaks with reproducible retention times 
were detected until 9 min of gradient. Peaks detected after 37 min were, 
on the other hand, strongly influenced by noise signal present (found in 
both samples and blanks) and potentially compromising quantitative 
analysis through affecting ionization efficiency. To determine presence 
or absence of the features to specific groups, feature must be present in 
60% of the samples within the group to be considered as the “true” fea-
ture. The partition of the detected features was visualized using Venny 
2.1 and Venn Diagram (Oliveros 2007). 
2.5  Statistical analysis 
Details on statistical analysis have been provided in “Supplementary 
Methods”. Briefly, Multivariate and univariate analyses were done us-
ing Microsoft Excel and Metaboanalyst 4.0 (Chong et al. 2019). One-way 
ANOVA was used to determine if features varied by tissue type. Similarly, 
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one way ANOVA was also used to determine if features varied by geno-
type. Statistics for this analysis have been provided in Supplemental Ta-
ble 4. Following data normalization and scaling, PLS-DA plots, heatmap, 
hierarchical clustering and volcano plots were generated using Metabo-
analyst for all analyses. For tissue partition analysis, the “in sample” ratio 
between hippocampus and cortex from the same mouse was calculated 
( KOHippo/ KOCortex and WTHippo/ WTCortex) and used in statistical analysis. 
Student’s t test (p < 0.05) and a fold change of ≥ 2 and ≤ 0.5 were used to 
determine differentially expressed metabolites which were then tenta-
tively identified using Human Metabolome Database (HMDB 2018 ver-
sion) and Lipid Maps structure database with mass tolerance of 10 ppm 
or ± 0.01 m/z in both databases, respectively (Wishart et al. 2017; Sud 
et al. 2007). Positive mode ion adducts, [M + H]+ and [M + NH4]+ were se-
lected for identification. The identifier with the lowest mass difference 
was chosen as the representative ID for this paper. 
2.6  Pathway analysis 
Corresponding KEGG IDs of the tentatively identified features were used 
in the Metaboanalyst Pathway Analysis module and the Reactome path-
way database. In Metaboanalyst, hypergeometric test and relative-be-
tweenness centrality were the algorithms used in overrepresentation 
analysis and pathway topology analysis, respectively. Statistics for Re-
actome pathway analysis have been provided in Supplemental Table 3. 
3  Results 
3.1  Overall analysis and data overview 
Using a genetic Kv1.1-KO mouse model of epilepsy, nonpolar metabo-
lites were extracted from hippocampal (WT, n = 5; KO, n = 5) and cor-
tex (WT, n = 5; KO, n = 5) tissue female mice. These regions were chosen 
due to initiation of generalized seizures in the hippocampus and sub-
sequent spreading to the cortex. Overall, 4323 features were detected 
when comparing both tissue types and genotypes. These features show 
98.7% (4266 features) overlap between all groups with 31 metabolites 
being unique to Kv1.1−/− cortical tissue and wild-type hippocampal and 
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cortical tissue (Fig. 1a). Six metabolites were unique to cortical tissue of 
both genotypes and two metabolites were unique to wild-type cortex. 
Finally, 17 metabolites were unique to cortical tissue of both genotypes 
and Kv1.1−/− hippocampal tissue. Hierarchical clustering suggested a 
trend of clustering based on genotype, however, this has some variabil-
ity (Fig. 1b). PLS-DA analysis showed variability which may be attrib-
uted to a high number of features (Fig. 1c). As a result, tissues were an-
alyzed separately in Metaboanalyst. 
3.2  Lipid partition between hippocampus and cortex 
Because hippocampal and cortical tissues have highly connected cir-
cuitry and are thus, communicative, the partition (or balance) of the in-
dividual lipid species in these tissues may play an important role in the 
seizure onset. Therefore, the “in sample” ratios (referred to as partition 
ratios hereon) of the lipids between hippocampus and cortex were cal-
culated and statistically analyzed (Table 1). The partition analysis re-
vealed, from the 4352 features that were detected, that the ratio 29 me-
tabolites were significantly changed (p < 0.05) and had a fold change of 
≥ 2 and ≤ 0.5 (Table 1). Twenty-two ratios had increased in response to 
the deletion of Kv1.1, indicating a higher intensity in the hippocampus; 
seven had decreased, indicating a higher intensity in the cortex. The 
classes of the metabolites consisted of glycerophospholipids and glyc-
erolipids. The upregulation of different lipid species could be indicative 
of increased flux through lipid production and signaling pathways or of 
structural remodeling of the cell membrane. Based on the m/z and RT 
of the specific lipid classes, 16 features were tentatively identified. For 
unidentified features, it can be suggested that they can also be attrib-
uted to glycerophospholipids (mostly cardiolipin) due to their m/z val-
ues and RT. 
3.3  Analysis of non‑polar metabolome of Kv1.1 null mice reveals 
changes in phospholipid levels in hippocampal tissue 
In order to examine if there are differentially expressed metabolites that 
may affect seizure susceptibility in the Kv1.1 KO genotype, additional sta-
tistics were done on the tissues separately. Of the features detected in 
the hippocampus, Students t-test and fold change analyses revealed that 
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Fig. 1 
a) Venn Diagram 
showing the 
uniqueness and 




on all features 
from each tissue. 





cortical tissue in 
addition to wild-
type vs. KV1.1−/−.   
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66 significantly changed features (p value < 0.05) with a fold change of 
0.5 < or > 2 and (Fig. 2a). PLS-DA appeared to separate WT and KO sam-
ples into two distinct groups (Fig. 2b). When these features are visual-
ized on a heatmap, they can be hierarchically clustered into WT and KO 
groups (Fig. 2c) suggesting lower “in group” variation and metabolic al-
terations contributed primarily to the genotypes and pro-epileptic con-
ditions. For tentative identification, both the m/z and RT of the specific 
lipid classes, were used. Of the compounds, 22 of them were tentatively 
Table 1  Metabolites with significant (p < 0.05) change in partition ratio. Ratios expressed as average of all 
mice within genotype (i.e. KOHippo/ KOCortex) (n = 5).
Feature#  M/z  RT  p value  FC  Log2(FC)  KOHippo/  WTHippo/  ID 
      KOCortex WTCortex
2245 1541.0223 28.39342 0.000907 6.8923 2.785 1.48200753 0.215023588 CL(78:13)
2339 1545.0439 30.19693 0.006922 4.262 2.0915 1.463586611 0.343399848 CL(78:11)
1540 619.52859 21.45607 0.009393 0.437 −1.1943 0.830521446 1.900523832  DG(36:3)
3076 914.54252 24.67435 0.01232 3.036 1.6022 1.691953198 0.557299834
3266 1224.8029 28.47826 0.015475 2.9849 1.5777 2.661825002 0.891769288
1161 1224.8033 27.96628 0.015729 2.5682 1.3608 2.39593153 0.932918216
3750 760.58833 23.15106 0.017241 4.4833 2.1646 2.374186746 0.52956004 PC(34:1)
3717 760.63915 13.83236 0.019338 4.7603 2.2511 2.016014007 0.423501454 TG(44:4)
3362 683.5033 20.55179 0.020438 0.24804 −2.0114 0.480660008 1.937868963 PA(P-36:3)
2924 1525.1976 15.98834 0.020848 2.4234 1.277 2.210609887 0.912186112
2082 379.28289 24.94067 0.021525 5.0457 2.3351 1.036299124 0.205382444 MG(20:4)
2660 844.67999 36.38692 0.024484 6.4056 2.6793 5.12294113 0.799755633 PE-Nme(42:1)
2579 738.03114 17.5781 0.025059 3.1307 1.6465 3.367349222 1.075576499
1108 1208.3911 24.68311 0.026134 2.6287 1.3943 2.288052422 0.870420822
2972 1196.7696 34.11828 0.026748 5.7922 2.5341 2.749256348 0.474646828 Ganglioside GM3 (36:2)
3661 841.53216 30.91421 0.027573 0.047042 −4.4099 0.00990206 0.126812919 PI(P-36:5)
3472 914.54248 24.59988 0.027738 3.6168 1.8547 1.832314343 0.506609079
1470 1524.1937 15.97183 0.027769 3.1886 1.6729 3.744400781 1.174307862
3510 1233.8481 31.37504 0.028188 0.10502 −3.2513 0.022294484 0.127725196
2665 760.64102 14.68543 0.029931 0.29305 −1.7708 1.45868118 4.977511093 TG(44:4)
3517 1497.0355 35.23429 0.031846 2.9383 1.555 1.353905614 0.460785799
4030 838.63259 14.46687 0.039145 0.23455 −2.092 0.984924332 4.19924118 PE-Nme(42:4)
1682 756.55241 15.49642 0.039495 3.0165 1.5929 1.894507631 0.62804463 PC(34:3)
1164 1520.1638 33.82245 0.040437 2.2832 1.1911 1.017646038 0.445704607
4280 1148.7733 34.60997 0.040507 4.3776 2.1301 4.343095949 0.992120507
3708 866.66418 17.30173 0.041693 3.9187 1.9704 2.445672862 0.6240973 PE-Nme(44:4)
4277 936.73614 25.33598 0.043101 0.44316 −1.1741 1.070164227 2.414839826
1671 816.63931 16.1634 0.046744 3.1983 1.6773 2.329997034 0.728515739 PC(38:1)
2670 869.65258 21.9099 0.049855 2.2549 1.173 2.156816436 0.956515904
Provided annotation represent simple M/z based fit and can be affected by in source fragmentation. Therefore, it is important to note 
that all identifications are tentative, and their validation would require additional characterization involving purified standards and 
extensive MSn analysis
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Fig. 2 a) Volcano plot of all features in the hippocampus. Compounds with a log2 fold 
change of > 2 (KO/WT) and a p value < 0.05 have been highlighted in pink. b) PLS-DA 
scores plots comparing lipidomic profiles between Kv1.1−/− and WT mice in the hip-
pocampus. c Heatmap detailing significant features in the hippocampus and the over-
all trend of upregulation in response to Kv1.1 knockout. Correlation of these features 
can also be seen by hierarchical clustering.   
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identified using HMDB and LMSD database searches. Results showed 
that many of these compounds consisted of the as glycerophospholipid 
including phosphatidylethanolamine (PE), phosphatidylcholine (PC), 
and cardiolipins (CL) apart from a glycerolipid (Supplementary Table 1). 
Of the identified compounds, all were upregulated except for a phospho-
glycerol. In addition, it can be suggested that the unidentified features 
can also be attributed to these lipid classes due to their m/z values and 
RT. Following fold change analysis, 58 features were upregulated and 
consisted of glycerophospholipids (mainly cardiolipin and phosphatidyl-
ethanolamines) while the 8 downregulated features consisted of phos-
phatidylglycerols or remain unidentified.  
3.4  Analysis of non‑polar metabolome reveals changes in  
phospholipid composition in cortex tissue 
Like hippocampus analysis, these samples can be grouped into WT and 
KO in all pairwise comparison, PLS-DA analysis and hierarchical clus-
tering (Fig. 3a–c). Seventy-two features had at least a fold change ≥ 2 
and a p value < 0.05 with 11 being upregulated and 61 being downreg-
ulated. Of those, 26 metabolites were tentatively identified using both 
LipidMaps and HMDB (Supplementary Table 2). However, due to the 
m/z values and RT, the unidentified features are likely to be glycero-
phospholipids. All phosphatidylinositols, phosphatidylserines, and some 
phosphatidylethanolamines were downregulated while a few cardio-
lipins and phosphtidylcholines were upregulated. This could be attrib-
uted to the hippocampus being the site of seizure initiation thus caus-
ing a breakdown between the communication between hippocampal 
and cortical tissue. 
3.5  Pathway enrichment analysis and overall patterns in fold 
changes 
Using Metaboanalyst and Reactome pathway enrichment analyses 
yielded similar results with Reactome providing detail on specific path-
ways affected. Generally, glycerophospholipid and sphingolipid synthe-
sis were impacted across both tissue types (Fig. 4a). Specifically, phos-
phatidylserine synthesis, phosphatidylglycerol synthesis and acyl chain 
remodeling of cardiolipin and phosphatidylethanolamine were changed 
J o h n s o n  e t  a l .  i n  M eta b o lo m i c s  1 6  ( 2 0 2 0 )       13
Fig. 3 a) Volcano plot of all features in the cortex. Compounds with a log2 fold change 
(KO/WT) of > 2 and a p value < 0.05 have been highlighted in pink. b) PLS-DA scores 
plot comparing lipid changes in Kv1.1−/− and WT cortex tissue in mice. c Heatmap 
detailing significant features found in the cortex and overall trend of downregulation 
in response to Kv1.1 knockout. Correlation of these features are also shown by hier-
archical clustering.  
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(Fig. 4b). Further, comparing all significant species’ differential regula-
tion found in all groups to other groups in which the lipid was not sig-
nificant yielded interesting observations (Fig. 5). First, the hippocam-
pus generally seemed to follow the overall pattern of the partition ratio, 
with most metabolites and partition ratios being upregulated in Kv1.1-
KO mice. This indicates that the increase observed in most partition ra-
tios upon Kv1.1-KO arise due to changes within the hippocampus. Addi-
tionally, the cortex continued its trend with most metabolites, including 
non-significant ones, being downregulated. 
4  Discussion 
Epilepsy is a chronic neurological disorder that is characterized by ab-
normal neuronal excitation. Although epileptic phenotypes have been 
Fig. 4 a) Affected pathways generated from KEGG ID input show that overall metabo-
lism of lipids is impacted. b) Phospholipid metabolic pathways comprise a majority of 
lipid metabolism pathways affected, namely synthesis and remodeling pathways. All 
pathways highlighted are significant (adjusted p < 0.05).   
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Fig. 5 Comprehensive look of all tentatively identified significant lipid species found in each analysis de-
scribed in this study and their respective fold changes (i.e. cortex, tissue, and partition ratio). “*” indi-
cates that the species in question was significantly (p < 0.05) changed within the specified group only. 
All Fold Changes expressed as Log2 fold change.   
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shown to be mediated by the KD, which ultimately results in a metabolic 
fuel switch (Lutas and Yellen 2013), the molecular mechanism of this 
effect is unknown. The Kv1.1-KO mouse model of epilepsy, which lacks 
some potassium channels critical to metabolic sensing and neuronal 
function through maintenance of negative membrane potential (Nich-
ols 2006), has been demonstrated to respond to the KD. Therefore, the 
analysis of nonpolar metabolites in brain tissue may provide insights 
into metabolic dynamics and indicates a potential effect of the KD on 
the epileptic phenotype. 
To evaluate overall profiles of lipids in two epilepsy relevant tissues, 
hippocampus and cortex, and genotypes (WT and Kv1.1 KO), multi-
variate analysis was performed. Vast majority of the detected features 
(98.7%; 4226 features) were found in all samples (Fig. 1). Statistical 
analysis revealed genotype over tissue clustering with a minimum of 
significantly changed features identified. This suggests that detailed, tis-
sue specific analyses were necessary. Additionally, simultaneous analy-
sis of cortex and hippocampus tissues from the same animal, allows for a 
unique “in sample” partition analysis of the individual lipids in those tis-
sues. It has been demonstrated that hippocampal and cortical brain neu-
ral connections can allow for the propagation and initiation of seizures 
(Barbarosie and Avoli 1997; Bragin et al. 1999). Additionally, the ratio 
of lipid classes rather than overall composition can give cellular mem-
branes different functions and characteristics (Farooqui et al. 2000). To 
determine if an imbalance of lipids between the cortex and the hippo-
campus regions could contribute to seizure propagation, the individ-
ual ratios of all features from the same animal have been calculated and 
statistically analyzed. The ratios of 29 metabolites (Table 1) were sig-
nificantly (p < 0.05) changed with a fold change of > 2 and < 0.5. Some 
metabolites were tentatively identified as glycerophospholipids and glyc-
erolipids. Many of the metabolites were found to be upregulated upon 
Kv1.1-KO, indicating a potential need for membrane remodeling and/ 
or increased flux through lipid production pathway to be used in down-
stream signaling pathways. Probably the most interesting tentatively 
identified lipids were DG(36:3) and a few cardiolipins. 
Reduced levels of DG(36:3) was discovered to be a marker of sleep re-
striction (Weljie et al. 2015). Interestingly, the Hippocampus/Cortex ra-
tio of this metabolite was found to be almost two-fold decreased in Kv1.1 
KO mice (Table 1). Although these results are consistent with original 
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findings, it may suggest that the changes in DG(36:3) are tissue specific 
rather than overall concentration. Insufficient sleep has been reported 
to be a comorbid condition with epilepsy, often increasing severity and 
frequency of seizures (Roundtree et al. 2016). The Kv1.1 KO model used 
in this study has also been reported to exhibit longer periods of activ-
ity during times of rest, indicating troubles with sleeping (Roundtree 
et al. 2016). The impact that DG(36:3) may ultimately have on epilepsy 
remains uncertain. However, other studies have suggested that diacylg-
lycerol kinases (DGKs) may impact neurotransmitter release and have 
been implicated in seizures and other neurological disorders (Shirai and 
Saito 2014). 
The partition ratio of cardiolipin(CL), was upregulated in response to 
Kv1.1 knockout (Table 1). CL is involved in mitochondrial function and 
complex formation and has also been identified as a target for redox 
function in brain injuries (Ji et al. 2012; Zhang et al. 2005). These mol-
ecules are a critical component of the inner mitochondrial membrane 
(IMM) that aids in mitochondrial bioenergetics through stabilization 
and organization of IMM proteins (Paradies et al. 2014). Oxidized CL 
has been shown to induce mitochondrial permeability transition pore 
opening which is also induced by calcium influx. Finally, ATP dynam-
ics are often disrupted in epilepsy (Lutas and Yellen 2013; McDonald et 
al. 2018). Within the Kv1.1-KO model of epilepsy, ketone bodies (prod-
ucts of the ketogenic diet) has been demonstrated to raise mitochon-
drial permeability thresholds within the hippocampus (Kim et al. 2015). 
The upregulation of CL ratios could be attributed to several factors in-
cluding tissue specific irreversible modifications of CLs or direct, tis-
sue specific increase in CL production. In general, the epileptic seizures 
are accompanied by high levels of oxidative stress, usually originating 
in mitochondria and its environment. This can lead to the oxidation of 
CLs proximal to these sites. In this case, the cortex tissue would be pri-
marily affected by oxidation decreasing the CL levels and increasing the 
Hippocampus/Cortex ratios. Increased CL oxidation and subsequent ac-
cumulation in cortex tissue may also contribute to seizure initiation. Al-
ternatively, the metabolic stress that occurs in seizures may lead to the 
tissue specific increased production of CL in order to stabilize the mi-
tochondrial membrane proteins, maintain ATP production, and to pre-
vent permeability pore opening. The third and most probable scenario 
includes both mechanisms. 
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Although the balances of lipid partition are important, their relative 
concentrations and patterns can be highly complementary and indicative 
of potential metabolic changes. In the tissue specific analysis, most of the 
tentatively identified, significantly changed compounds consisted of glyc-
erophospholipids, many of them being (PI, PE, CL) (Supplementary Table 
1 and 2). Together with the tentatively identified molecules in the par-
tition analysis, the most affected pathway were related to lipid biosyn-
thesis and remodeling (Fig. 4a and b) When observing the fold change 
in response to the knockout, metabolites tended to be upregulated in 
the hippocampus and downregulated in the cortex with some excep-
tions (Supplementary Tables 1 and 2). These results, together with par-
tition analysis, where many metabolites were increased upon Kv1.1−/−, 
could indicate that this increase may be localized to the hippocampus 
rather than the cortex (Fig. 5). The hippocampus is typically regarded 
as a “seizure gate” or controls seizure initiation (Barbarosie and Avoli 
1997; Bragin et al. 1999). This suggests that seizure activity must be ini-
tiated in the hippocampus before it spreads to cortical regions. Further, 
Kv1.1 channels are densely clustered at the juxtaparanodal region close 
to the nodes of Ranvier and at axonal initial segments as these sites are 
responsible for action potential initiation (Robbins and Tempel 2012). 
Kv1.1 channels at these regions serve to limit excitatory activity. Ad-
ditionally, lipid accumulation upon seizure induction and propagation 
has been observed along with an increase in phospholipase enzyme ac-
tivity (Bazan et al. 2002). This may explain the upregulation of various 
glycerophospholipids, specifically phosphocholine and phosphoethanol-
amine in the hippocampus as it could reflect an elevated inflammatory 
response to seizure initiation and propagation. Subsequently, the path-
ways affected in the Kv1.1−/− were glycerophospholipid, sphingolipid, 
and glycosylphosphatidylinositol (GPI)-anchor biosynthesis (Fig. 4). By 
affecting these pathways, the subsequent impacts on membrane main-
tenance and signaling could aid in hyperexcitation. 
In the brain, phospholipids maintain the neuronal integrity through 
regulating ion channel function and by supplying the brain’s energetic 
needs, and thus are critical to controlling neuronal excitation (Oliver et 
al. 2004). Approximately 20% of the brain’s energy requirements are 
generated through fatty acid oxidation, which takes place in the mito-
chondrial matrix (Ebert et al. 2003; Tracey et al. 2018). In other neuro-
logical conditions such as ALS, mitochondria become damaged, glucose 
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is not a preferred fuel source, and lipid catabolic activity increases (Ma-
grané et al. 2014, Dodge et al. 2013). Thus, the changes observed in 
the lipidome of the Kv1.1−/− model of epilepsy could be explained by 
changes in metabolic activity and/or compromised structural integrity 
in cellular membranes. It was demonstrated that the increase in adrener-
gic activity in seizures results in a decrease in lipogenic activity (Botion 
and Doretto 2003). Phospholipids account for a majority of lipid com-
position in cellular membranes. Changes in membrane structure could 
result in hyperexcitability through ion channels and pumps. In the hip-
pocampus, PE was commonly upregulated, a lipid critical to membrane 
fluidity and metabolism. Increased PE was observed to increase fluid-
ity of the membrane which could cause changes in vesicular transport 
(i.e. glutamate and GABA) (Thiam et al. 2013). Further, PE can be syn-
thesized in and localized to the mitochondria where it was shown to be 
critical for the cytochrome bc1 complex function which is responsible 
for ATP synthesis (Calzada et al. 2019). The changes observed in the 
lipidome may be consequential of required increase in ATP production 
to meet energetic demands of seizure activity (Wasterlain et al. 2010). 
Given the KD’s effectiveness in seizure attenuation, it would be impor-
tant to see the KD’s further impacts on the epileptic hippocampal and 
cortical neurochemical makeup. 
5 Conclusion 
In conclusion, FT-ICR/MS was employed to examine changes in the lipi-
dome associated with a Kv1.1 KO model of epilepsy. The presented study 
finds changes in overall lipid distribution between the hippocampus and 
cortex in this model. The general consequences of this change result 
in loss of membrane integrity and synaptic signaling changes. Specifi-
cally, our study suggests that increased levels of CL in the hippocampus 
may be indicative of seizure initiation and altered mitochondrial func-
tion upon Kv1.1 KO. The limitations of this study include limited sam-
ple sizes (n = 5 per condition) which does not allow for biomarker de-
termination and limited ability for PLS-DA evaluation. Additionally, the 
lack of access to MS/MS fragmentation at time of data collection means 
that any IDs provided above are only tentative and not putative. None-
theless, this study provides one of few descriptions of general changes 
J o h n s o n  e t  a l .  i n  M eta b o lo m i c s  1 6  ( 2 0 2 0 )        20
in lipid metabolism associated with epilepsy and may open potential av-
enues for development of new therapies.  
Supplementary material  Supplementary Methods and Supplementary Tables 1–4 
follow the References. Supplementary Table 5 (.xlsx) is attached to the article archive 
record.
Acknowledgments This work was supported by grants from the National Institute of 
Health (P20 RR017675, P20 GM104320, NS085389, NS072179 and NS111389) and 
from Citizens United for Research in Epilepsy Foundation.  
Author contributions A.J., R.A.G., D.M., C.H.T.B., H.K. and K.Sa. carried out experiments; 
A.J., R.A.G., D.M., C.H.T.B., C.B., K.Si., T.S., T.H., C.K.H. and J.A. performed data analysis and 
interpretation; A.J. and J.A. wrote paper with input from all the authors.    
Conflict of interest The authors declare no competing financial interests.  
References 
Baek, B. S., Kwon, H. J., Lee, K. H., Yoo, M. A., Kim, K. W., Ikeno, Y., et al. (1999). 
Regional difference of ROS generation, lipid peroxidaton, and antioxidant enzyme 
activity in rat brain and their dietary modulation. Archives of Pharmacal Research, 
22(4), 361–366.  https://doi.org/10.1007/bf02979058  
Barbarosie, M., & Avoli, M. (1997). CA3-driven hippocampal-entorhinal loop controls 
rather than sustains in vitro limbic seizures. The Journal of Neuroscience, 17(23), 
9308–9314.  https://doi.org/10.1523/jneurosci.17-23-09308.1997  
Bazan, N. G., Tu, B., & Turco, E. B. R. D. (2002). What synaptic lipid signaling tells us 
about seizure-induced damage and epileptogenesis. Progress in Brain Research, 
135, 175–185.  https://doi.org/10.1016/s0079-6123(02)35017-9  
Botion, L. M., & Doretto, M. C. (2003). Changes in peripheral energy metabolism 
during audiogenic seizures in rats. Physiology & Behavior, 78(4–5), 535–541.  
https://doi.org/10.1016/s0031-9384(03)00061-1  
Bragin, A., Engel, J., Wilson, C. L., Fried, I., & Mathern, G. W. (1999). Hippocampal and 
entorhinal cortex high-frequency oscillations (100-500 Hz) in human epileptic 
brain and in kainic acid-treated rats with chronic seizures. Epilepsia, 40(2), 127–
137.  https://doi.org/10.1111/j.1528-1157.1999.tb02065.x  
Calzada, E., Avery, E., Sam, P. N., Modak, A., Wang, C., McCaffery, J. M., et al. (2019). 
Phosphatidylethanolamine made in the inner mitochondrial membrane is 
essential for yeast cytochrome bc1 complex function. Nature Communications.  
https://doi.org/10.1038/s41467-019-09425-1  
Chong, J., Wishart, D. S., & Xia, J. (2019). Using MetaboAnalyst 4.0 for comprehensive 
and integrative metabolomics data analysis. Current Protocols in Bioinformatics.  
https://doi.org/10.1002/cpbi.86  
J o h n s o n  e t  a l .  i n  M eta b o lo m i c s  1 6  ( 2 0 2 0 )       21
Dodge, J. C., Treleaven, C. M., Fidler, J. A., Tamsett, T. J., Bao, C., Searles, M., et al. 
(2013). Metabolic signatures of amyotrophic lateral sclerosis reveal insights into 
disease pathogenesis. Proceedings of the National Academy of Sciences of the USA, 
110, 10812–10817.  https://doi.org/10.1073/pnas.1308421110  
Ebert, D., Haller, R. G., & Walton, M. E. (2003). Energy contribution of octanoate 
to intact rat brain metabolism measured by 13C nuclear magnetic resonance 
spectroscopy. Journal of Neuroscience, 23, 5928–5935. 
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000). Glycerophospholipids in brain: 
their metabolism, incorporation into membranes, functions, and involvement in 
neurological disorders. Chemistry and Physics of Lipids, 106(1), 1–29.  https://doi.
org/10.1016/s0009-3084(00)00128-6  
Fenoglio-Simeone, K. A., Wilke, J. C., Milligan, H. L., Allen, C. N., Rho, J. M., & Maganti, 
R. K. (2009). Ketogenic diet treatment abolishes seizure periodicity and improves 
diurnal rhythmicity in epileptic Kcna1-null mice. Epilepsia, 50(9), 2027–2034. 
https://doi.org/10.1111/j.1528-1167.2009.02163.x  
Folch, J., Lees, M., & Stanley, G. H. S. (1957). A simple method for the isolation and 
purification of total lipides from animal tissues. Journal of Biological Chemistry, 
226(1), 497–509. 
Guzman, P. D., Dantuono, M., & Avoli, M. (2004). Initiation of electrographic seizures 
by neuronal networks in entorhinal and perirhinal cortices in vitro. Neuroscience, 
123(4), 875–886. https://doi.org/10.1016/j.neuroscience.2003.11.013  
Huttenlocher, P. R. (1976). Ketonemia and seizures: Metabolic and anticonvulsant 
effects of two ketogenic diets in childhood epilepsy. Pediatric Research, 10(5), 
536–540. https://doi.org/10.1203/00006450-197605000-00006  
Jernerén, F., Söderquist, M., & Karlsson, O. (2015). Post-sampling release of 
free fatty acids—Effects of heat stabilization and methods of euthanasia. 
Journal of Pharmacological and Toxicological Methods, 71, 13–20.  https://doi.
org/10.1016/j.vascn.2014.11.001  
Ji, J., Kline, A. E., Amoscato, A., Samhan-Arias, A. K., Sparvero, L. J., Tyurin, V. A., et al. 
(2012). Lipidomics identifies cardiolipin oxidation as a mitochondrial target for 
redox therapy of brain injury. Nature Neuroscience, 15(10), 1407–1413.  https://
doi.org/10.1038/nn.3195  
Kalilani, L., Sun, X., Pelgrims, B., Noack-Rink, M., & Villanueva, V. (2018). The 
epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. 
Epilepsia, 59(12), 2179–2193.  https://doi.org/10.1111/epi.14596  
Kelly, K. M., & Chung, S. S. (2011). Surgical treatment for refractory epilepsy: Review 
of patient evaluation and surgical options. Epilepsy Research and Treatment, 2011, 
1–10.  https://doi.org/10.1155/2011/303624  
Kim, D. Y., Simeone, K. A., Simeone, T. A., Pandya, J. D., Wilke, J. C., Ahn, Y., et al. (2015). 
Ketone bodies mediate antiseizure effects through mitochondrial permeability 
transition. Annals of Neurology, 78(1), 77–87.  https://doi.org/10.1002/
ana.24424  
Kunduri, G., Turner-Evans, D., Konya, Y., Izumi, Y., Nagashima, K., Lockett, S., et al. 
(2018). Defective cortex glia plasma membrane structure underlies light-induced 
epilepsy in cpes mutants. Proceedings of the National Academy of Sciences.  
https://doi.org/10.1073/pnas.1808463115  
J o h n s o n  e t  a l .  i n  M eta b o lo m i c s  1 6  ( 2 0 2 0 )        22
Lutas, A., & Yellen, G. (2013). The ketogenic diet: Metabolic influences on brain 
excitability and epilepsy. Trends in Neurosciences, 36(1), 32–40.  https://doi.
org/10.1016/j.tins.2012.11.005  
Magrané, J., Cortez, C., Gan, W. B., & Manfredi, G. (2014). Abnormal mitochondrial 
transport and morphology are common pathological denominators in SOD1 and 
TDP43 ALS mouse models. Human Molecular Genetics, 23, 1413–1424.  https://
doi.org/10.1093/hmg/ddt528  
McDonald, T., Puchowicz, M., & Borges, K. (2018). Impairments in oxidative glucose 
metabolism in epilepsy and metabolic treatments thereof. Frontiers in Cellular 
Neuroscience.  https://doi.org/10.3389/fncel.2018.00274  
Miranda, A. M., Bravo, F. V., Chan, R. B., Sousa, N., Paolo, G. D., & Oliveira, T. G. (2019). 
Differential lipid composition and regulation along the hippocampal longitudinal 
axis. Translational Psychiatry.  https://doi.org/10.1038/s41398-019-0478-6  
Naudí, A., Cabré, R., Jové, M., Ayala, V., Gonzalo, H., Portero-Otín, M., et al. (2015). 
Lipidomics of human brain aging and Alzheimers disease pathology. International 
Review of Neurobiology Omic Studies of Neurodegenerative Disease: Part B.  
https://doi.org/10.1016/bs.irn.2015.05.008  
Nichols, C. G. (2006). KATP channels as molecular sensors of cellular metabolism. 
Nature, 440(7083), 470–476.  https://doi.org/10.1038/natur e04711  
Oliver, D., Lien, C., Soom, M., Baukrowitz, T., Jonas, P., & Fakler, B. (2004). Functional 
conversion between A-type and delayed rectifier K channels by membrane lipids. 
Science, 304(5668), 265–270.  https://doi.org/10.1126/science.1094113   
Oliveros, J. C. (2007). VENNY. An interactive tool for comparing lists with Venn 
Diagrams. Retrieved from http://bioinfogp.cnb.csic.es/tools/venny/index.html  
Paradies, G., Paradies, V., Benedictis, V. D., Ruggiero, F. M., & Petrosillo, G. (2014). 
Functional role of cardiolipin in mitochondrial bioenergetics. Biochimica 
Et Biophysica Acta (BBA) - Bioenergetics, 1837(4), 408–417.  https://doi.
org/10.1016/j.bbabio.2013.10.006  
Pearson-Smith, J., & Patel, M. (2017). Metabolic dysfunction and oxidative stress in 
epilepsy. International Journal of Molecular Sciences, 18(11), 2365.  https://doi.
org/10.3390/ijms18112365  
Pluskal, T., Castillo, S., Villar-Briones, A., & Oresic, M. (2010). MZmine 2: modular 
framework for processing, visualizing, and analyzing mass spectrometry-
based molecular profile data. BMC Bioinform, 11, 395–395.  https://doi.
org/10.1186/1471-2105-11-395  
Robbins, C. A., & Tempel, B. L. (2012). Kv1.1 and Kv1.2: similar channels, 
different seizure models. Epilepsia, 53, 134–141. https://doi.
org/10.1111/j.1528-1167.2012.03484.x  
Roundtree, H. M., Simeone, T. A., Johnson, C., Matthews, S. A., Samson, K. K., & 
Simeone, K. A. (2016). Orexin receptor antagonism improves sleep and reduces 
seizures in Kcna1-null mice. Sleep, 39(2), 357–368.  https://doi.org/10.5665/
sleep.5444  
Shirai, Y., & Saito, N. (2014). Diacylglycerol kinase as a possible therapeutic target 
for neuronal diseases. Journal of Biomedical Science, 21(1), 28.  https://doi.
org/10.1186/1423-0127-21-28  
J o h n s o n  e t  a l .  i n  M eta b o lo m i c s  1 6  ( 2 0 2 0 )       23
Simeone, K. A., Matthews, S. A., Samson, K. K., & Simeone, T. A. (2014a). Targeting 
deficiencies in mitochondrial respiratory complex I and functional uncoupling 
exerts anti-seizure effects in a genetic model of temporal lobe epilepsy and in 
a model of acute temporal lobe seizures. Experimental Neurology, 251, 84–90.  
https://doi.org/10.1016/j.expne urol.2013.11.005  
Simeone, T. A., Samson, K. K., Matthews, S. A., & Simeone, K. A. (2014b). In vivo 
ketogenic diet treatment attenuates pathologic sharp waves and high frequency 
oscillations in in vitro hippocampal slices from epileptic Kv1.1α knockout mice. 
Epilepsia. https://doi.org/10.1111/epi.12603  
Sooderberg, M., Edlund, C., Alafuzoff, I., Kristensson, K., & Dallner, G. (1992). Lipid 
composition in different regions of the brain in Alzheimers disease/senile 
dementia of Alzheimers type. Journal of Neurochemistry, 59(5), 1646–1653.  
https://doi.org/10.1111/j.1471-4159.1992.tb10994.x  
Stas, J. I., Bocksteins, E., Jensen, C. S., Schmitt, N., & Snyders, D. J. (2016). The 
anticonvulsant retigabine suppresses neuronal KV2- mediated currents. Scientific 
Reports.  https://doi.org/10.1038/srep35080  
Sud, M., Fahy, E., Cotter, D., Brown, A., Dennis, E. A., Glass, C. K., et al. (2007). LMSD: 
LIPID MAPS structure database. Nucleic Acids Research.  https://doi.org/10.1093/
nar/gkl838  
Thiam, A. R., Farese, R. V., Jr., & Walther, T. C. (2013). The biophysics and cell biology 
of lipid droplets. Nature Reviews Molecular Cell Biology, 14, 775–786.  https://doi.
org/10.1038/nrm3699  
Tracey, T. J., Steyn, F. J., Wolvetang, E. J., & Ngo, S. T. (2018). Neuronal lipid 
metabolism: multiple pathways driving functional outcomes in health and 
disease. Frontiers in Molecular Neuroscience, 11(10), 1–25. 
Turker, S., Severcan, M., Ilbay, G., & Severcan, F. (2014). Epileptic seizures induce 
structural and functional alterations on brain tissue membranes. Biochimica 
Et Biophysica Acta (BBA)—Biomembranes, 1838(12), 3088–3096.  https://doi.
org/10.1016/j.bbamem.2014.08.025  
Vismer, M. S., Forcelli, P. A., Skopin, M. D., Gale, K., & Koubeissi, M. Z. (2015). The 
piriform, perirhinal, and entorhinal cortex in seizure generation. Frontiers in 
Neural Circuits.  https://doi.org/10.3389/fncir.2015.00027  
Wasterlain, C. G., Thompson, K. W., Suchomelova, L., & Niquet, J. (2010). Brain energy 
metabolism during experimental neonatal seizures. Neurochemical Research, 
35(12), 2193–2198.  https://doi.org/10.1007/s11064-010-0339-4  
Weljie, A. M., Meerlo, P., Goel, N., Sengupta, A., Kayser, M. S., Abel, T., et al. (2015). 
Oxalic acid and diacylglycerol 36:3 are cross-species markers of sleep debt. 
Proceedings of the National Academy of Sciences, 112(8), 2569–2574.  https://doi.
org/10.1073/pnas.1417432112  
Wenk, M. R. (2005). The emerging field of lipidomics. Nature Reviews Drug Discovery, 
4(7), 594–610.  https://doi.org/10.1038/nrd1776  
Wenzel, H. J., Vacher, H., Clark, E., Trimmer, J. S., Lee, A. L., Sapolsky, R. M., et 
al. (2007). Structural consequences of Kcna1 gene deletion and transfer 
in the mouse hippocampus. Epilepsia, 48(11), 2023–2046.  https://doi.
org/10.1111/j.1528-1167.2007.01189.x  
J o h n s o n  e t  a l .  i n  M eta b o lo m i c s  1 6  ( 2 0 2 0 )        24
Wishart, D. S., Feunang, Y. D., Marcu, A., Guo, A. C., Liang, K., Vázquez-Fresno, R., et 
al. (2017). HMDB 4.0: the human metabolome database for 2018. Nucleic Acids 
Research.  https://doi.org/10.1093/nar/gkx108  
Zhang, M., Mileykovskaya, E., & Dowhan, W. (2005). Cardiolipin is essential 
for organization of complexes III and IV into a supercomplex in intact yeast 
mitochondria. Journal of Biological Chemistry, 280(33), 29403–29408.  https://
doi.org/10.1074/jbc.m504955200    

Supplementary Methods and Supplementary Tables 1–4 follow.
SUPPLEMENTAL METHODS 
 
Sample Analysis and Data processing 
 
Standard Operational Procedures (SOP) 
To maximize quality of the output all samples were analyzed by a series of steps defined by 
Standard Operational Procedures (SOP). Reproducibility was monitored and ensured within the 
system with procedures implemented to identify any changes and shifts in the platform during 
sample analyses. Procedure including injection of blank (extraction solvent without sample) to 
characterize chromatographic background, running lipid standards to calibrate retention times 
specific to individual lipid classes and pooled sample (Mix of all samples analyzed) after every 
10th sample. This technique is well-established and suitable for long-term metabolic studies to 
monitor instrument performance and enable comparison of data acquired in different times. With 
limited number of samples included in the study, pool sample was injected at the beginning, in 
the middle, and in the end of the analysis and used to confirm acceptable retention time and 
mass accuracy shifts. As retention time calibration standards, the SPLASH LIPIDOMIX mass 
spec standard was used (Avanti Polar Lipids, Inc.). For sample randomization, a random 
number was assigned to each sample using the “RAND()” function in Microsoft Excel; these 
numbers were then sorted in ascending order.   
Data Pre-Processing 
For overall feature description, features that were not detected in 60% of a sample group were 
deemed as a “false positive” and subsequently deleted. In other words, if the feature was 
present in less than 40% of the sample of the specific group, it was considered as the absent 
feature. Before tables were put through Metaboanalyst for statistical analysis, additional 
trimming of the data was done. Retention times before 9 mins and after 37 mins were deleted 
due to these signals being attributed to overall noise.  
Data Analysis 
Multivariate, univariate and partition analyses were done using a combination of 
Metaboanalyst and Microsoft Excel. For the partition analysis, a ratio of the hippocampus 
intensity divided by the cortex intensity of the same animal was calculated for each feature. This 
resulted in five ratios for wild type and five ratios for the Kv1.1-/- genotype which were then used 
for statistical analysis. Ratios then represent a distribution of the individual metabolites in 
various brain sections and may more accurately reflect metabolic disbalance between these 
tissues. The p-values were calculated using Metaboanalyst software. Here, any features 
missing 50% of values were removed and remaining missing values were imputed with 
minimum values. Then, auto scaling was used for normalization due to having the best result. 
After this, raw p-values (p<0.05) and a fold-change (FC) threshold of >2 from the volcano plot 
feature were used to determine significance. 
For multivariate analyses (comparing both genotypes and tissues), IQR filtering was 
used for variable filtering. No missing value imputation was performed; however, this did not 
affect overall results. After this, Pareto scaling was used to normalize the data. For the 
dendrogram, average algorithm with Euclidean distance measure was used for hierarchical 
clustering. Average clustering was chosen here because it is suggested to be less affected by 
outliers (Manning et al., 2009). PLS-DA score plots have been reported. One-way ANOVA 
analysis was used to determine significant features in multivariate analysis (ANOVA p<0.05). 
However, most of this difference appeared to be due to tissue. Because of this, the tissues were 
analyzed separately in univariate analyses.  
For univariate analysis of hippocampal and cortical tissue, data scaling and 
normalization in followed the same steps described above for multivariate analysis in 
Metaboanalyst. Again, raw p-values and a FC threshold of >2 were obtained from the volcano 
plot were used for statistical significance (t-test p<0.05). Only the significant features were used 
to construct the heatmaps. Here, average clustering with Euclidean distance measure was used 
for hierarchical clustering on the heatmap as well. In general, average clustering seemed to 
performed better than other types of clustering.  
Finally, calculation of FDR values for univariate analyses was performed in Microsoft 
Excel using normalized data files from Metaboanalyst. Upon evaluation, it was found that 
Metaboanalyst uses this file to provide the raw p.values in the Volcano Plot feature. Further, it 
was also found this software makes certain assumptions on normality for statistical tests, which 
the authors were unable to replicate by hand, thus indicating a need to calculate FDR values in 
Excel. FDR was calculated using the modified adjusted p-value equation previously described 
by Benjamini et al. (Benjamini et al., 2009). In cases where the FDR was larger than 1, it was 
reported as 1 per Benjamini et al.  
Pathway Enrichment Analysis:  
KEGG IDs were uploaded to Reactome and Metaboanalyst for pathway enrichment analyses. 
Reactome provided more detailed pathway analysis so this has been reported. Pathways with 
an adjusted p<0.05 have been reported in Supplemental Table 3. 
Data Availability  
Raw data files have been uploaded to Metabolights under the identifier MTBLS1432.  
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Feature # m/z RT FC log2(FC) P-value 
FDR 
Adjusted Short ID 
1596 805.6804 17.33943 6.6148 2.7257 0.001835 1 PE(P-40:0) 
3236 805.6803 17.41749 7.158 2.8396 0.002111 1 PE(P-40:0) 
3251 1468.133 34.93075 2.4255 1.2783 0.002424 1  
2072 366.2752 24.57469 2.5501 1.3505 0.0031 1  
1874 721.508 23.56639 0.32177 -1.6359 0.00328 1 PG(32:1)  
2813 805.6803 17.3425 8.2376 3.0422 0.004201 1 PE(P-40:0) 
2702 1468.013 32.05603 2.8979 1.535 0.006018 1  
3779 261.8834 15.52717 4.2261 2.0793 0.007772 1  
2329 380.3334 31.75663 15.063 3.9129 0.009662 1  
794 754.5924 29.17341 2.2535 1.1722 0.010182 1 PG(O-34:0) 
3750 760.5883 23.15106 2.2198 1.1504 0.012076 1 PC(34:1) 
1938 890.5429 26.91772 0.044447 -4.4918 0.012169 1  
3003 1572.124 14.94142 21.054 4.396 0.012651 1  
764 1520.164 33.20648 2.1164 1.0816 0.012915 1  
3649 757.5592 21.91843 2.527 1.3374 0.013462 1  
3678 757.5592 21.92988 2.527 1.3374 0.013462 1  
1436 1068.855 15.50998 3.0112 1.5903 0.013591 1  
3588 1467.008 32.0779 3.9677 1.9883 0.014728 1 CL(72:8) 
1459 1176.806 15.58658 3.2719 1.7101 0.01488 1  
1339 1573.127 14.93007 13.572 3.7625 0.015828 1  
3984 754.5369 24.80512 2.482 1.3115 0.017101 1 PE-Nme(36:4) 
2245 1541.022 28.39342 4.4296 2.1472 0.017972 1 CL(78:13) 
570 954.6145 33.69582 2.3656 1.2422 0.018175 1  
3716 1552.214 15.43915 11.596 3.5356 0.01838 1  
3209 1552.214 15.45704 11.131 3.4766 0.018591 1  
2364 845.683 34.93253 4.068 2.0243 0.018792 1 PE(42:2) 
2978 261.5502 27.07187 2.0975 1.0687 0.020343 1  
4120 261.5502 27.1761 2.0975 1.0687 0.020343 1  
2049 261.5502 27.26315 2.0975 1.0687 0.020343 1  
2171 1175.794 32.51479 2.4129 1.2708 0.021869 1  
1670 957.6335 15.43628 14.058 3.8133 0.023282 1  
3383 787.6016 13.69755 0.32294 -1.6306 0.02344 1 PE(38:3) 
3504 926.5838 24.70426 3.588 1.8432 0.024252 1 PI(40:7) 
3567 800.5576 15.54927 2.1358 1.0948 0.025085 1  
2944 1069.859 15.5041 4.9474 2.3067 0.025425 1  
1283 1408.921 14.73127 34.71 5.1173 0.025952 1  
2224 721.5079 23.47945 0.4033 -1.3101 0.026486 1 PG(32:1)  
2012 1467.008 33.30824 2.7447 1.4566 0.027521 1 CL(72:8) 
3345 707.5424 24.59149 2.0914 1.0644 0.029419 1 PE(32:1) 
1667 755.5405 24.70032 2.1603 1.1112 0.029579 1 PE(36:5) 
3673 1177.809 15.523 4.2656 2.0927 0.030377 1  
1607 1524.194 15.59228 4.4293 2.1471 0.030901 1  
2889 868.6545 28.887 2.0113 1.0081 0.030961 1  
2194 754.5369 24.64252 2.0658 1.0467 0.031782 1 PC(34:4) 
1595 1168.905 15.0744 20.288 4.3426 0.031924 1  
2426 244.2031 25.36605 2.0872 1.0616 0.033169 1  
3303 721.5079 23.59777 0.36282 -1.4627 0.034232 1 PC(32:1) 
4314 815.6361 14.64364 151.23 7.2406 0.034396 1 PE(40:3) 
2050 261.5502 26.86422 2.1659 1.115 0.035917 1  
3265 394.3594 14.9575 161.05 7.3314 0.036537 1  
3697 381.8011 15.71498 2.1554 1.108 0.037577 1  
2798 1005.633 28.62599 2.5077 1.3263 0.037656 1  
4480 1222.909 24.40043 0.3295 -1.6016 0.03798 1  
3037 1551.211 15.31432 32.688 5.0307 0.038769 1  
2825 393.2985 31.11233 0.006621 -7.2388 0.039512 1  
3702 791.6286 14.72898 2478 11.275 0.040491 1 PE(38:1) 
2082 379.2829 24.94067 3.6557 1.8701 0.042749 1 MG(20:4) 
4374 1524.195 15.44396 61.601 5.9449 0.043143 1  
812 982.6454 15.28588 2.152 1.1056 0.043331 1  
2829 366.2752 24.58939 2.1575 1.1094 0.044552 1  
1162 1576.214 15.89356 0.34666 -1.5284 0.04554 1  
3018 1577.217 15.06711 11.541 3.5287 0.045589 1 CL(79:2) 
3953 202.6638 26.77265 0.005455 -7.5183 0.046649 1  
1363 1551.212 15.43339 5.0114 2.3252 0.047624 1  
3801 1004.63 27.05943 0.007853 -6.9926 0.047642 1  
3224 1468.013 32.39941 2.9967 1.5834 0.049627 1  
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The 66 significant (p<0.05) features identified in the hippocampus. A majority were 
found to be elevated in Kv1.1-/- mice compared to WT mice. *Provided annotation 
represent simple m/z based fit and can be affected by in source fragmentation. 
Therefore, it is important to note that all identifications are tentative, and their 
validation would require additional characterization involving purified standards and 
extensive MSn analysis 
Feature # m/z RT FC log2(FC) raw.pval 
FDR 
adjusted Short ID 
1299 814.6329 14.73945 0.13966 -2.84 0.000166 0.43288 PC(38:2) 
3472 914.5425 24.59988 0.3084 -1.6971 0.000236 0.205397  
1280 814.633 14.99347 0.26675 -1.9065 0.000871 0.568522 PC(38:2) 
2991 1174.791 31.86965 0.34684 -1.5277 0.001732 0.904421 CL(50:0) 
2947 722.5105 28.00696 0.3749 -1.4154 0.002429 1 PE(P-36:5) 
2327 1233.848 31.82244 0.22093 -2.1783 0.003575 1  
3154 820.6549 15.5586 0.40052 -1.32 0.003868 1  
2562 1233.848 31.81339 0.20263 -2.3031 0.005147 1  
2369 1006.636 27.45407 0.21073 -2.2466 0.005404 1  
4129 380.8331 32.45385 0.37374 -1.4199 0.00672 1  
3166 1550.209 15.23505 0.10784 -3.213 0.006859 1 CL(78:0) 
363 785.5866 15.5675 0.41812 -1.258 0.007912 1 PE(38:4) 
3770 1006.636 27.94557 0.19498 -2.3586 0.008492 1  
4291 749.6262 24.32968 0.29166 -1.7777 0.008633 1 PE(O-36:1) 
1161 1224.803 27.96628 0.44834 -1.1573 0.008788 1  
2498 820.6549 15.57486 0.38718 -1.3689 0.009279 1  
2557 1621.197 27.75514 0.10265 -3.2842 0.009655 1  
1648 1467.009 32.04239 3.1574 1.6588 0.009886 1 CL(72:8) 
1345 865.8023 25.29234 2.026 1.0186 0.010126 1  
3622 1494.141 32.42368 0.39287 -1.3479 0.010148 1 CL(74:0) 
4309 815.6357 14.81104 0.34835 -1.5214 0.010584 1 PC(37:3) 
1695 1621.197 27.77078 0.10893 -3.1985 0.011908 1  
1569 1155.865 24.23256 0.47406 -1.0769 0.01355 1  
1822 1004.63 27.68436 0.43616 -1.1971 0.013741 1  
1557 1542.026 28.38132 2.4591 1.2981 0.01395 1  
1463 1524.194 15.86755 0.23477 -2.0907 0.01493 1  
3668 1523.174 31.71586 0.30101 -1.7321 0.015374 1  
2809 844.6778 34.33316 0.38698 -1.3697 0.015676 1 PC(40:1) 
1209 890.5426 27.18703 0.22929 -2.1247 0.017345 1  
2255 998.6842 31.94537 0.25286 -1.9836 0.017809 1  
1226 405.3548 27.58432 0.43996 -1.1846 0.018992 1  
3760 1006.636 27.46526 0.2512 -1.9931 0.019263 1  
3018 1577.217 15.06711 0.22564 -2.1479 0.01969 1 CL(79:2) 
4107 844.679 34.43789 0.43941 -1.1864 0.020669 1 PE-Nme(42:1) 
3430 1496.032 34.32715 2.209 1.1434 0.020817 1 PE(39:0) 
2886 1516.007 28.75586 2.3292 1.2198 0.021161 1  
2176 1621.196 27.52772 0.1338 -2.9018 0.021301 1  
3136 790.6242 15.06812 0.4262 -1.2304 0.021374 1  
3056 1525.198 15.58724 0.1862 -2.4251 0.022725 1  
976 980.2633 24.74696 0.40427 -1.3066 0.023868 1  
1415 749.5892 14.12978 0.3006 -1.7341 0.024495 1 PC(32:1) 
3716 1552.214 15.43915 0.29245 -1.7737 0.027501 1  
2854 1004.63 27.70717 0.45671 -1.1306 0.028299 1  
3740 789.611 31.30576 0.27674 -1.8534 0.029302 1 PE(38:2) 
1647 1467.009 32.11813 2.9307 1.5512 0.029597 1 CL(72:8) 
2476 1519.037 32.7923 2.1062 1.0746 0.029614 1 CL(76:10) 
2058 843.6677 21.19209 0.34564 -1.5326 0.029935 1 PE(42:3) 
3591 1149.777 33.13192 0.39444 -1.3421 0.031373 1  
3703 748.5861 14.0809 0.42893 -1.2212 0.032071 1 PE(36:0) 
1386 955.6178 32.7929 2.3592 1.2383 0.032286 1  
677 754.5925 28.44314 0.3883 -1.3648 0.033994 1 PG(O-34:0) 
705 1005.633 27.64443 0.39288 -1.3478 0.03416 1  
1363 1551.212 15.43339 0.25269 -1.9845 0.034263 1  
4466 929.6025 32.72561 0.40798 -1.2934 0.034478 1  
2823 381.2941 31.6383 0.4224 -1.2433 0.035093 1  
2884 956.6287 15.8191 0.28795 -1.7961 0.036059 1 PI(42:6) 
1670 957.6335 15.43628 0.056933 -4.1346 0.037095 1  
1680 381.8011 15.70146 0.41856 -1.2565 0.037404 1  
1567 957.6326 15.77882 0.36869 -1.4395 0.037676 1  
1899 1539.008 27.22972 2.8311 1.5013 0.038088 1 CL(78:14) 
1655 846.6223 25.95805 0.47233 -1.0821 0.038317 1 PS(40:1) 
1304 734.5701 13.49471 2.2821 1.1904 0.038615 1 PC(32:0) 
1150 1224.804 27.56426 0.41547 -1.2672 0.040406 1  
1741 202.6617 27.69458 0.4333 -1.2066 0.041306 1  
2604 1497.15 32.67889 0.23595 -2.0835 0.041714 1 CL(73:0) 
3107 842.5236 31.45648 0.33019 -1.5986 0.045006 1  
1829 1496.147 32.43288 0.40848 -1.2917 0.046265 1  
3142 814.6329 14.71548 0.31155 -1.6825 0.046423 1 PC(38:2) 
2216 1149.777 33.05973 0.33391 -1.5825 0.046514 1  
2771 1540.011 26.85571 0.41683 -1.2625 0.047434 1  
3446 1516.007 28.81365 2.2273 1.1553 0.048227 1  
3224 1468.013 32.39941 3.1057 1.6349 0.049675 1  
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72 significant (p<0.05) features identified in the cortex with almost all compounds being 
downregulated in the Kv1.1 -/- compared to the WT. Retention times and m/z have 
been included 
 
Pathway Raw P.value  FDR Adjusted 
P.Value 
Synthesis of PS 1.08e-05 7.47e-04 
Acyl chain remodeling of CL 4.33e-05 0.001 
Acyl chain remodeling of PE 5.08e-05 0.001 
Synthesis of PC 2.19e-04 0.004 
Sphingolipid de novo 
biosynthesis 
3.68e-04 0.005 
Sphingolipid metabolism 0.001 0.015 
Glycerophospholipid biosynthesis  0.003 0.017 
 
 
Pathways that were significantly (adj. p<0.05) affected via Reactome pathway database search 
 
Supplementary Table 4
m/z value RT f.value p.value #NAME? FDR Fisher's LSD
424 396.275 19.76391 21.557 7.26E‐06 5.1393 0.018945 KOCor ‐ KOHippo; WTCor ‐ KOCor; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
1791 858.602 21.65573 17.172 2.95E‐05 4.5302 0.03851 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
151 1517.079 19.76555 15.575 5.26E‐05 4.279 0.04487 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
602 277.5532 21.25262 13.991 9.76E‐05 4.0105 0.04487 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
1007 277.8878 21.25241 13.711 0.000109 3.9608 0.04487 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
117 798.5423 20.38461 13.486 0.00012 3.9204 0.04487 WTCor ‐ KOCor; WTHippo ‐ KOCor; WTCor ‐ KOHippo; WTCor ‐ WTHippo
868 241.5277 19.75385 13.232 0.000134 3.8742 0.04487 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
1 792.5542 19.76686 13.043 0.000145 3.8395 0.04487 KOCor ‐ KOHippo; WTCor ‐ KOCor; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
72 724.5292 19.76568 12.701 0.000168 3.7755 0.04487 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
1410 928.5918 18.58358 12.441 0.000188 3.7264 0.04487 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
39 651.5357 19.76859 12.191 0.00021 3.6782 0.04487 KOCor ‐ KOHippo; WTCor ‐ KOCor; WTCor ‐ KOHippo; WTCor ‐ WTHippo
83 264.2063 19.72722 12.105 0.000218 3.6614 0.04487 KOCor ‐ KOHippo; WTCor ‐ KOCor; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
2677 901.5633 17.62285 12.051 0.000223 3.6509 0.04487 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
425 850.6082 19.76686 11.863 0.000243 3.6141 0.045349 KOCor ‐ KOHippo; KOCor ‐ WTHippo; WTCor ‐ KOHippo; WTCor ‐ WTHippo
311 878.5701 18.35129 11.671 0.000265 3.576 0.046209 KOCor ‐ KOHippo; WTCor ‐ KOCor; WTCor ‐ KOHippo; WTCor ‐ WTHippo
